Tendon/Ligament and Enthesis Injuries: Repair and Regeneration
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Regenerative Engineering".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 425
Special Issue Editors
Interests: musculoskeletal tissue engineering; artificial intelligence; biomaterials; computer vision; microscopy; label-free analysis
Interests: nanobiological materials; biosensing technology; precision theranostics
Interests: macrophage-based therapies for musculoskeletal regeneration; pathologies of challenging musculoskeletal disorders; nanoparticle-based therapy and tissue engineering on musculoskeletal regeneration
Special Issue Information
Dear Colleagues,
Tendons and ligaments are crucial for connecting muscles to bones and are prone to injuries, particularly at the bone–tendon junction or enthesis as well as at the mid-tendon/ligament region. This collection presents a range of original research articles and reviews that cover topics on tendon/ligaments and entheses, from fundamental musculoskeletal science to technical advancements in tissue engineering and regenerative medicine. This collection will cover areas such as the isolation and modification of stem cells and their derivatives including exosomes, the controlled delivery of tendon/ligament bioactive molecules, the characterization and assessment of tendon/ligament and bone–tendon therapeutics including miRNA, mRNA, drugs, and biomaterials, and the development and use of in vitro and in vivo musculoskeletal models, such as tissue-on-a-chip technologies and (patho)physiologically relevant animal models.
Dr. Dai Fei Elmer Ker
Dr. Jingyu Shi
Dr. Bingyang Dai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tendon
- ligament
- enthesis
- drug delivery
- therapeutics
- biomaterials
- tissue engineering
- musculoskeletal animal models
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
